In breast cancer, the most widely adopted combination of tumour markers are carcinoembryonic antigen (CEA) and mucin (MUC1), commonly detected as cancer antigen (CA) 15-3 [4]. This evidence concerns the gene CEACAM5 and breast carcinoma.